Diastolic Abnormalities as the First Feature of Hypertrophic Cardiomyopathy in Dutch Myosin-Binding Protein C Founder Mutations

JACC: Cardiovascular Imaging

Volumn 2, Issue 1, 2009, Pages 58-64

  Michels, Michelle ^a   Soliman, Osama I I ^a   Kofflard, Marcel J ^b   Hoedemaekers, Yvonne M ^a   Dooijes, Dennis ^a   Majoor Krakauer, Danielle ^a   ten Cate, Folkert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

hypertrophic cardiomyopathy; myosin binding protein C; tissue Doppler imaging

Indexed keywords

ARGININE; MYOSIN BINDING PROTEIN C;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FAMILY STUDY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NETHERLANDS; PRIORITY JOURNAL; SYSTOLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; CASE-CONTROL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOUNDER EFFECT; GENOTYPE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MASS SCREENING; MIDDLE AGED; MUTATION; NETHERLANDS; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 58149328530     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.08.003     Document Type: Article

References (27)

1. Elliott P., Andersson B., Arbustini E., et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 29 (2008) 270-276
2. Niimura H., Bachinski L.L., Sangwatanaroj S., et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338 (1998) 1248-1257
3. Watkins H., Rosenzweig A., Hwang D.S., et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326 (1992) 1108-1114
4. Olivotto I., Maron M.S., Adabag A.S., et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 480-487
5. Michels M., Hoedemaekers Y.M., Kofflard M.J., et al. Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J 15 (2007) 184-190
6. Marian A.J. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 355 (2000) 58-60
7. Rust E.M., Albayya F.P., and Metzger J.M. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin Invest 103 (1999) 1459-1467
8. Nagueh S.F., Kopelen H.A., Lim D.S., et al. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 102 (2000) 1346-1350
9. Nagueh S.F., Bachinski L.L., Meyer D., et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104 (2001) 128-130
10. Ho C.Y., Sweitzer N.K., McDonough B., et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105 (2002) 2992-2997
11. Alders M., Jongbloed R., Deelen W., et al. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J 24 (2003) 1848-1853
12. McKenna W.J., Spirito P., Desnos M., Dubourg O., and Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77 (1997) 130-132
13. Nagueh S.F., Lakkis N.M., Middleton K.J., Spencer III W.H., Zoghbi W.A., and Quinones M.A. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99 (1999) 254-261
14. Khouri S.J., Maly G.T., Suh D.D., and Walsh T.E. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 17 (2004) 290-297
15. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., and Quinones M.A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30 (1997) 1527-1533
16. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
17. Ackerman M.J., Van Driest S.L., Ommen S.R., et al. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol 39 (2002) 2042-2048
18. Van Driest S.L., Jaeger M.A., Ommen S.R., et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 602-610
19. Richard P., Charron P., Carrier L., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107 (2003) 2227-2232
20. Van Driest S.L., Vasile V.C., Ommen S.R., et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 1903-1910
21. Charron P., Dubourg O., Desnos M., et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96 (1997) 214-219
22. Rottbauer W., Gautel M., Zehelein J., et al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest 100 (1997) 475-482
23. Hofmann P.A., Hartzell H.C., and Moss R.L. Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol 97 (1991) 1141-1163
24. Korte F.S., McDonald K.S., Harris S.P., and Moss R.L. Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ Res 93 (2003) 752-758
25. Kulikovskaya I., McClellan G., Flavigny J., Carrier L., and Winegrad S. Effect of MyBP-C binding to actin on contractility in heart muscle. J Gen Physiol 122 (2003) 761-774
26. Stelzer J.E., Dunning S.B., and Moss R.L. Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. Circ Res 98 (2006) 1212-1218
27. Pohlmann L., Kroger I., Vignier N., et al. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 101 (2007) 928-938